Portal de Periódicos da CAPES

Cyclophosphamide as a first-line therapy in LGL leukemia

2013; Springer Nature; Volume: 28; Issue: 5 Linguagem: Francês

10.1038/leu.2013.359

1476-5551

Aline Moignet, Zainul S. Hasanali, Renato Zambello, Laura Pavan, Benoît Bareau, Olivier Tournilhac, Mikaël Roussel, Thierry Fest, Amir Awwad, Kendall Thomas Baab, Gianpietro Semenzato, Roch Houot, Thomas P. Loughran, Thierry Lamy,

Immunodeficiency and Autoimmune Disorders

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not.The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés. Cyclophosphamide as a first-line therapy in LGL leukemia